Synergy CHC Corp. (Uplisting) (SNYR) Competitors $4.50 -0.62 (-12.11%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends SNYR vs. GOSS, GNFT, SLDB, MDWD, KYTX, IPHA, SGMT, DRUG, CRBP, and ACTUShould you be buying Synergy CHC Corp. (Uplisting) stock or one of its competitors? The main competitors of Synergy CHC Corp. (Uplisting) include Gossamer Bio (GOSS), Genfit (GNFT), Solid Biosciences (SLDB), MediWound (MDWD), Kyverna Therapeutics (KYTX), Innate Pharma (IPHA), Sagimet Biosciences (SGMT), Bright Minds Biosciences (DRUG), Corbus Pharmaceuticals (CRBP), and Actuate Therapeutics (ACTU). These companies are all part of the "pharmaceutical products" industry. Synergy CHC Corp. (Uplisting) vs. Gossamer Bio Genfit Solid Biosciences MediWound Kyverna Therapeutics Innate Pharma Sagimet Biosciences Bright Minds Biosciences Corbus Pharmaceuticals Actuate Therapeutics Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and Gossamer Bio (NASDAQ:GOSS) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership. Is SNYR or GOSS more profitable? Synergy CHC Corp. (Uplisting)'s return on equity of 0.00% beat Gossamer Bio's return on equity.Company Net Margins Return on Equity Return on Assets Synergy CHC Corp. (Uplisting)N/A N/A N/A Gossamer Bio N/A -127.28%-22.12% Does the media prefer SNYR or GOSS? In the previous week, Synergy CHC Corp. (Uplisting)'s average media sentiment score of 0.00 equaled Gossamer Bio'saverage media sentiment score. Company Overall Sentiment Synergy CHC Corp. (Uplisting) Neutral Gossamer Bio Neutral Which has preferable earnings & valuation, SNYR or GOSS? Synergy CHC Corp. (Uplisting) has higher earnings, but lower revenue than Gossamer Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynergy CHC Corp. (Uplisting)$26.01M1.51N/AN/AN/AGossamer Bio$105.32M1.81-$179.82M-$0.32-2.63 Does the MarketBeat Community believe in SNYR or GOSS? Gossamer Bio received 151 more outperform votes than Synergy CHC Corp. (Uplisting) when rated by MarketBeat users. CompanyUnderperformOutperformSynergy CHC Corp. (Uplisting)N/AN/AGossamer BioOutperform Votes15166.23% Underperform Votes7733.77% Do insiders & institutionals believe in SNYR or GOSS? 81.2% of Gossamer Bio shares are owned by institutional investors. 5.0% of Gossamer Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend SNYR or GOSS? Gossamer Bio has a consensus price target of $9.20, suggesting a potential upside of 995.24%. Given Gossamer Bio's stronger consensus rating and higher possible upside, analysts plainly believe Gossamer Bio is more favorable than Synergy CHC Corp. (Uplisting).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Gossamer Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryGossamer Bio beats Synergy CHC Corp. (Uplisting) on 8 of the 10 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Synergy CHC Corp. (Uplisting) News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNYR vs. The Competition Export to ExcelMetricSynergy CHC Corp. (Uplisting)Medicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$39.17M$378.11M$14.03B$9.08BDividend YieldN/AN/A2.79%4.23%P/E RatioN/A32.5921.9717.18Price / Sales1.516.082.66116.95Price / CashN/A10.6621.1437.86Price / BookN/A1.885.854.78Net IncomeN/A-$50.37M$572.90M$225.60M7 Day Performance-14.61%-3.56%-1.85%-1.23%1 Month Performance-25.25%-7.00%-3.05%3.36%1 Year PerformanceN/A-6.41%2.93%16.60% Synergy CHC Corp. (Uplisting) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNYRSynergy CHC Corp. (Uplisting)N/A$4.50-12.1%N/AN/A$39.17M$26.01M0.0040Positive NewsGap UpGOSSGossamer Bio3.622 of 5 stars$0.84-9.3%$9.20+990.4%-1.4%$191.19M$105.32M-2.61180GNFTGenfit1.1979 of 5 stars$3.80-0.5%$13.00+242.1%+2.2%$189.96M$41.31M0.00120Positive NewsSLDBSolid Biosciences4.0837 of 5 stars$4.64-5.5%$15.22+228.1%-15.8%$185.41M$8.09M-1.61100MDWDMediWound1.9106 of 5 stars$17.15-0.8%$27.50+60.3%+58.3%$184.98M$19.72M-5.9380Positive NewsGap DownKYTXKyverna Therapeutics2.4246 of 5 stars$4.24-4.1%$25.71+506.5%N/A$183.05M$7.03M0.0096News CoverageIPHAInnate Pharma2.7604 of 5 stars$2.25-25.5%$11.50+411.1%-23.5%$182.18M$24.85M0.00220News CoverageGap DownHigh Trading VolumeSGMTSagimet Biosciences2.3237 of 5 stars$5.75+31.0%$23.00+300.0%-8.0%$176.35M$2M0.008Gap UpHigh Trading VolumeDRUGBright Minds Biosciences3.5821 of 5 stars$39.64-3.3%$75.00+89.2%+2,621.8%$175.76MN/A-60.29N/ANews CoverageCRBPCorbus Pharmaceuticals3.8067 of 5 stars$14.34-4.9%$62.00+332.4%+147.6%$174.66M$880,000.00-3.2240ACTUActuate TherapeuticsN/A$8.87+2.9%N/AN/A$173.25MN/A0.0010Gap Up Related Companies and Tools Related Companies Gossamer Bio Competitors Genfit Competitors Solid Biosciences Competitors MediWound Competitors Kyverna Therapeutics Competitors Innate Pharma Competitors Sagimet Biosciences Competitors Bright Minds Biosciences Competitors Corbus Pharmaceuticals Competitors Actuate Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNYR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synergy CHC Corp. (Uplisting) Please log in to your account or sign up in order to add this asset to your watchlist. Share Synergy CHC Corp. (Uplisting) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNYR Stock Alerts